DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Alatrofloxacin

Alatrofloxacin

  • TROVAN® Tablets(Trovafloxacin Mesylate)

    TROVAN® Tablets(Trovafloxacin Mesylate)

  • Exploiting the Potential of Transforming Anti-Bacterial Xacins

    Exploiting the Potential of Transforming Anti-Bacterial Xacins

  • CPT / HCPCS Code Drug Description Approximate Cost Share

    CPT / HCPCS Code Drug Description Approximate Cost Share

  • CLOSED PODS Information Sheets

    CLOSED PODS Information Sheets

  • Standing Order for Tularemia Prophylaxis

    Standing Order for Tularemia Prophylaxis

  • Appendix C Medication Tables

    Appendix C Medication Tables

  • Aminoglycosides) – Inhibition of Transpeptidation (Chloramphenicol) – Inhibition of Trna Translocation (Erythromycin) Resistance

    Aminoglycosides) – Inhibition of Transpeptidation (Chloramphenicol) – Inhibition of Trna Translocation (Erythromycin) Resistance

  • I the Mutant-Prevention Concentration (MPC)

    I the Mutant-Prevention Concentration (MPC)

  • Wo 2008/127291 A2

    Wo 2008/127291 A2

  • Fluoroquinolones Reported Hepatotoxicity

    Fluoroquinolones Reported Hepatotoxicity

  • Page 1 FINLANDS FÖRFATTNINGSSAMLING Utgiven I Helsingfors

    Page 1 FINLANDS FÖRFATTNINGSSAMLING Utgiven I Helsingfors

  • (12) United States Patent (10) Patent No.: US 8,383,154 B2 Bar-Shalom Et Al

    (12) United States Patent (10) Patent No.: US 8,383,154 B2 Bar-Shalom Et Al

  • Wo 2007/095187 A2

    Wo 2007/095187 A2

  • WHO-EMP-RHT-TSN-2018.1-Eng.Pdf

    WHO-EMP-RHT-TSN-2018.1-Eng.Pdf

  • Avelox®) SMC No

    Avelox®) SMC No

  • (12) Patent Application Publication (10) Pub. No.: US 2009/0264342 A1 Cottarel Et Al

    (12) Patent Application Publication (10) Pub. No.: US 2009/0264342 A1 Cottarel Et Al

  • Poison Or Antibiotic? a Guide to

    Poison Or Antibiotic? a Guide to "Class" Entries

  • Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs

    Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs

Top View
  • Review of Properties and Analytical Methods for the Determination of Norfloxacin
  • Target Drug Discovery (TDD)
  • Quinolines-Based SARS-Cov-2 3Clpro and Rdrp Inhibitors and Spike-RBD-ACE2 Inhibitor for Drug-Repurposing Against COVID-19: an in Silico Analysis
  • Lääkeluettelon Aineet, Liite 1. Ämnena I
  • Resistance Pattern of Escherichia Coli to Levofloxacin in Iran: a Narrative Review
  • TROVAN /ZITHROMAX Compliance Pak (Trovafloxacin Mesylate/Azithromycin for Oral Suspension)
  • 1 Annex I Summary of Product Characteristics
  • Antibiotic Usage in South Africa: a Longitudinal Analysis of Medicine Claims Data
  • Treatment of Experimental Bacterial Keratitis with Topical Trovafloxacin
  • (12) United States Patent (10) Patent No.: US 9.211,259 B2 Friedman Et Al
  • Pharmaceutical Appendix to the Tariff Schedule 2
  • [Product Monograph Template
  • Probable Levofloxacin-Induced Thrombocytopenia in a Patient Previously on Ciprofloxacin: a Case Report and Literature Review
  • Medications That May Cause Dry Mouth a Adipost Alka Seltzer Plus Cold & Flu Liqui‐Gels A‐Spas S/L Advil Alka Seltzer Plus Cold Medicine Effervescent Tabs A.R.M
  • (INN-Nimet) 8.12.2020
  • Pharmaceuticals Appendix
  • Title: Repurposing of Approved Drugs with Potential to Block SARS-Cov-2 Surface Glycoprotein Interaction with Host Receptor
  • Disease Planning Guide - Anthrax Mass Post Exposure Prophylaxis


© 2024 Docslib.org    Feedback